I do think they have a special advisor that has written numerous and oft used FDA regulation text books and whom is considered a strong authority on the subject. I’d imagine LP listens intently to what this expert has to say regarding data lock, and consults his input as to when it might finally be the right time to move forward with that important milestone.
Market Data 
Markets 
AI
